{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:30:45Z","timestamp":1791189045332,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.atherosclerosis.2008.01.001","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T01:27:03Z","timestamp":1205890023000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"title":["Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: Possible protective effects and therapeutic applications of bilirubin"],"prefix":"10.1016","volume":"198","author":[{"given":"Harvey A.","family":"Schwertner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libor","family":"V\u00edtek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2423(06)43001-8","article-title":"The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases","volume":"43","author":"V\u00edtek","year":"2007","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib2","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1161\/CIRCULATIONAHA.105.598698","article-title":"Heme oxygenase-1: a novel drug target for atherosclerotic diseases?","volume":"114","author":"Stocker","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib3","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/01.ATV.0000178169.95781.49","article-title":"Heme oxygenase and atherosclerosis","volume":"25","author":"Morita","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0008-6363(98)00278-8","article-title":"Heme oxygenase-carbon monoxide signaling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?","volume":"41","author":"Siow","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/paa.1999.111.5.438","article-title":"Heme oxygenase: Recent advances in understanding its regulation and role","volume":"111","author":"Elbirt","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1096\/fj.04-3485cmt","article-title":"Heme oxygenase-1: A therapeutic amplification funnel","volume":"19","author":"Bach","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/156652307780363134","article-title":"Heme oxygenase-1 gene therapy: Recent advances and therapeutic applications","volume":"7","author":"Abraham","year":"2007","journal-title":"Curr Gene Therapy"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib8","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.2174\/1381612033453776","article-title":"Role of heme oxygenase-1 in cardiovascular function","volume":"9","author":"Perrella","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tips.2007.03.006","article-title":"Restoring HOmeostasis: is heme oxygenase-1 ready for the clinic?","volume":"28","author":"Scott","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib10","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1542\/peds.113.6.1776","article-title":"Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle","volume":"113","author":"Sedlak","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"Stocker","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm0196-87","article-title":"Heme oxygenase: A novel target for the modulation of the inflammatory response","volume":"2","author":"Willis","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0304-4165(93)90013-X","article-title":"A beneficial role of bile pigments as an endogenous tissue protector: Anticomplement effects of biliverdin and conjugated bilirubin","volume":"1158","author":"Nakagami","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib15","doi-asserted-by":"crossref","first-page":"16712","DOI":"10.1016\/S0021-9258(19)89449-8","article-title":"Free and albumin-bound bilirubin are efficient co-antioxidants for \u03b1-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation","volume":"269","author":"Neuzil","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0006-2952(95)02395-X","article-title":"Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins","volume":"51","author":"Wu","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0021-9150(97)00232-3","article-title":"Association of smoking and low serum bilirubin antioxidant concentrations","volume":"136","author":"Schwertner","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0021-9150(01)00601-3","article-title":"Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels","volume":"160","author":"V\u00edtek","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/hc3901.095897","article-title":"Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits","volume":"104","author":"Ishikawa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.RES.88.5.506","article-title":"Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice","volume":"88","author":"Ishikawa","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4161\/cc.6.1.3700","article-title":"Bilirubin and biliverdin treatment of atherosclerotic diseases","volume":"6","author":"Ollinger","year":"2007","journal-title":"Cell Cycle"},{"issue":"Suppl. 2","key":"10.1016\/j.atherosclerosis.2008.01.001_bib22","first-page":"A235","article-title":"Relationship between serum bilirubin and markers of inflammation and oxidative stress (abstract)","volume":"22","author":"V\u00edtek","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/89068","article-title":"Heme oxygenase-1 protects against vascular constriction and proliferation","volume":"7","author":"Duckers","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/hh1401.093314","article-title":"Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice","volume":"89","author":"Yet","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib25","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0022-2275(20)32564-5","article-title":"Hemin binding and oxidation of lipoproteins in serum: Mechanism and effect on the interaction of LDL with human macrophages","volume":"39","author":"Camejo","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib26","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1073\/pnas.91.3.1183","article-title":"Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and \u03b1-tocopherol content","volume":"91","author":"Tribble","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9343(00)00700-2","article-title":"Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small dense low-density lipoproteins","volume":"110","author":"Tribble","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib28","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/art.22749","article-title":"Pharmacologic induction of heme oxygenase 1 reduces inflammatory arthritis in mice","volume":"56","author":"Benallaoua","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/clinchem\/40.1.18","article-title":"Association of low serum concentrations of bilirubin with increased risk of coronary artery disease","volume":"40","author":"Schwertner","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/01.ATV.16.2.250","article-title":"Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease","volume":"16","author":"Hopkins","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib31","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/clinchem\/40.10.1987","article-title":"Is bilirubin protective against coronary artery disease?","volume":"40","author":"Breimer","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib32","first-page":"185","article-title":"Relationship between bilirubin, apolipoprotein B, and coronary artery disease","volume":"27","author":"Levinson","year":"1997","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/CCLM.2000.078","article-title":"Comparison of laboratory parameters as risk factors for the presence and the extent of coronary or carotid atherosclerosis: the significance of apolipoprotein B to apolipoprotein all ratio","volume":"38","author":"Cerne","year":"2000","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0021-9150(00)00420-2","article-title":"Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study","volume":"154","author":"Hunt","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/01.STR.32.2.580-b","article-title":"High serum bilirubin level is inversely associated with the presence of carotid plaque","volume":"32","author":"Ishizaka","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib36","first-page":"44","article-title":"The effect of peripheral vascular disease on the serum levels of natural anti-oxidants: bilirubin and albumin","volume":"21","author":"Krijgsman","year":"2002","journal-title":"Int Angiol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.ejhg.5200842","article-title":"A genome scan for loci influencing anti-atherogenic serum bilirubin levels","volume":"10","author":"Kronenberg","year":"2002","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib38","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1373\/49.7.1201","article-title":"Is low serum bilirubin an independent risk factor for coronary artery disease in men but not in women?","volume":"49","author":"Endler","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib39","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1161\/01.ATV.0000185806.61430.7c","article-title":"High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions","volume":"25","author":"Gullu","year":"2005","journal-title":"Arterioscler Throm Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000091966","article-title":"The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis","volume":"21","author":"V\u00edtek","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib41","first-page":"1262","article-title":"Diagnostic value of bilirubin concentrations compared with novel and traditional biomarkers in atherosclerosis with coronary artery disease","volume":"27","author":"Yilmaz","year":"2006","journal-title":"Saudi Med J"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.atherosclerosis.2005.05.011","article-title":"Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women","volume":"184","author":"Erdogan","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib43","first-page":"522","article-title":"Diagnostic value of homocysteine, C-reactive protein and bilirubin for coronary artery disease","volume":"13","author":"Yilmaz","year":"2007","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/ATVBAHA.107.153262","article-title":"Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004","volume":"28","author":"Perlstein","year":"2008","journal-title":"Arteriocler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib45","first-page":"146","article-title":"Serum total bilirubin level is inversely associated with likelihood of nonfatal stroke: National Health and Nutrition Examination Survey, 1999\u20132004 (abstract)","volume":"12","author":"Perlstein","year":"2007","journal-title":"Vasc Med"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib46","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/jama.298.12.1398-b","article-title":"Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes","volume":"298","author":"Inoguchi","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib47","first-page":"685","article-title":"Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation","volume":"21","author":"Ganotakis","year":"2007","journal-title":"In Vivo"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib48","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/clinchem\/41.10.1504","article-title":"Serum bilirubin and risk of ischemic heart disease in middle-aged British men","volume":"41","author":"Breimer","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib49","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.ATV.16.8.912","article-title":"Evidence for a major gene elevating serum bilirubin concentration in Utah pedigrees","volume":"16","author":"Hunt","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib50","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0002-9149(01)01494-1","article-title":"Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study","volume":"87","author":"Djousse","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib51","first-page":"887","article-title":"Serum bilirubin and 10-year mortality risk in a Belgian population","volume":"12","author":"Temme","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0002-9149(02)03256-3","article-title":"Effect of serum albumin and bilirubin on the risk of myocardial infarction (the Framingham Offspring Study)","volume":"91","author":"Djousse","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.hjr.0000230097.81202.9f","article-title":"Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME)","volume":"14","author":"Troughton","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib54","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/15353702-0322805-29","article-title":"Inverse relationship between serum bilirubin and atherosclerosis in men. A meta-analysis of published studies","volume":"228","author":"Novotn\u00fd","year":"2003","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-8278(02)00359-8","article-title":"Inherited disorders of bilirubin metabolism","volume":"38","author":"Bosma","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib56","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1373\/49.7.1180","article-title":"UGT1A1*28 allele and coronary heart disease: The Rotterdam Study","volume":"49","author":"Bosma","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib57","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.106.633206","article-title":"Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study","volume":"114","author":"Lin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib58","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1373\/49.7.1039","article-title":"Bilirubin concentration, UGT1A1*28 polymorphism, and coronary artery disease","volume":"49","author":"Schwertner","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib59","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1373\/clinchem.2006.078667","article-title":"Further evidence that the UGT1A1*28 allele is not associated with coronary artery heart disease: The ECTIM Study","volume":"52","author":"Gajdos","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/174182679600300508","article-title":"Serum bilirubin and cardiovascular risk factors in a Chinese population","volume":"3","author":"Ko","year":"1996","journal-title":"J Cardiovascular Risk"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0021-9150(97)06088-7","article-title":"Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults","volume":"131","author":"Madhavan","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib62","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0895-7061(99)00049-7","article-title":"Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia","volume":"12","author":"Papadakis","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib63","first-page":"387","article-title":"Decreased levels of advanced glycation end-product in patients with Gilbert syndrome","volume":"51","author":"Kalousov\u00e1","year":"2005","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/j.1742-1241.2006.00907.x","article-title":"Low serum bilirubin concentrations are associated with impaired aortic elastic properties, but not impaired left ventricular diastolic function","author":"Caliskan","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib65","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1440-1746.2006.04564.x","article-title":"Urinary excretion of oxidative metabolites of bilirubin in subjects with Gilbert syndrome","volume":"22","author":"V\u00edtek","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib66","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9150(99)00387-1","article-title":"Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease","volume":"150","author":"Schwertner","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib67","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.freeradbiomed.2004.09.009","article-title":"The antioxidant defense proteinheme oxygenase 1 is a novel target for statins in endothelial cells","volume":"37","author":"Grosser","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib68","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.0000140694.67251.9C","article-title":"Simvastatin induces heme oxygenase-1: A novel mechanism for vessel protection","volume":"110","author":"Lee","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib69","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1139\/Y07-077","article-title":"Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection","volume":"85","author":"Muchova","year":"2007","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1291\/hypres.30.341","article-title":"Reduced expression of heme oxygenase-1 in patients with coronary atherosclerosis","volume":"30","author":"Brydun","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib71","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.mehy.2004.11.050","article-title":"Iatrogenic Gilbert syndrome\u2014A strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin","volume":"69","author":"McCarty","year":"2007","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib72","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/dmrr.666","article-title":"Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease","volume":"22","author":"Schindhelm","year":"2006","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib73","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.atherosclerosis.2006.04.006","article-title":"Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study","volume":"191","author":"Schindhelm","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib74","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.21171","article-title":"Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States","volume":"43","author":"Ioannou","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2008.01.001_bib75","first-page":"314A","article-title":"Fasting serum bilirubin concentrations and the risk of subsequent coronary heart disease death in men (abstract)","volume":"32","author":"Wei","year":"2000","journal-title":"Hepatology"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:29:33Z","timestamp":1758155373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915008000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0021915008000531"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.01.001","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: Possible protective effects and therapeutic applications of bilirubin","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}